The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Epigenome editing strategies for the functional annotation of CTCF insulators
Open accessAbstract
The human genome is folded into regulatory units termed ‘topologically-associated domains’ (TADs). Genome-wide studies support a global role for the insulator protein CTCF in mediating chromosomal looping and the topological constraint of TAD boundaries. However, the impact of individual insulators on enhancer-gene interactions and transcription remains poorly understood. Here, we investigate epigenome editing strategies for perturbing individual CTCF insulators and evaluating consequent effects on genome topology and transcription. We show that fusions of catalytically-inactive Cas9 (dCas9) to transcriptional repressors (dCas9-KRAB) and DNA methyltransferases (dCas9-DNMT3A, dCas9-DNMT3A3L) can selectively displace CTCF from specific insulators, but only when precisely targeted to the cognate motif. We further demonstrate that stable, partially-heritable insulator disruption can be achieved through combinatorial hit-and-run epigenome editing. Finally, we apply these strategies to simulate an insulator loss mechanism implicated in brain tumorigenesis. Our study provides strategies for stably modifying genome organization and gene activity without altering the underlying DNA sequence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CRISPRoff can perturb enhancers.
“Our initial experiments demonstrate CRISPRoff can perturb enhancers, opening the potential to target genome elements that control tissue-specific gene expression (Fulco et al., 2016; Tarjan et al., 2019).”
From Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing (2021) · cites this paper as Tarjan et al., 2019
In Results, under “Epigenome editing can disrupt CTCF at topological insulators” (page unavailable), the paper says dCas9-KRAB can repress enhancer function. Its experiments, however, target CTCF insulators, and our copy does not identify or test CRISPRoff as an enhancer-perturbing method. (LLM, conf=0.83)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A 3D Map of the Human Genome at Kilobase Resolution Reveals Principles of Chromatin Looping
Rao, S. S. P., Huntley, M. H., Durand, N. C., Stamenova, E. K., Bochkov, I. D., Robinson, J. T., Sanborn, A. L., Machol, I., Omer, A. D., Lander, E. S., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.021 · Cited by 9,212
Topological domains in mammalian genomes identified by analysis of chromatin interactions
Dixon, J. R., Selvaraj, S., Yue, F., Kim, A., Li, Y., Shen, Y., Hu, M., Liu, J. S., & Ren, B. (2012) · Nature · doi:10.1038/nature11082 · Cited by 6,829
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637
Cohesin Loss Eliminates All Loop Domains
Rao, S. S. P., Huang, S.-C., Glenn St Hilaire, B., Engreitz, J. M., Perez, E. M., Kieffer-Kwon, K.-R., Sanborn, A. L., Johnstone, S. E., Bascom, G. D., Bochkov, I. D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.026 · Cited by 1,883
Self-citationMethylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene
Bell, A. C., & Felsenfeld, G. (2000) · Nature · doi:10.1038/35013100 · Cited by 1,746
Nora, E. P., Goloborodko, A., Valton, A.-L., Gibcus, J. H., Uebersohn, A., Abdennur, N., Dekker, J., Mirny, L. A., & Bruneau, B. G. (2017) · Cell · doi:10.1016/j.cell.2017.05.004 · Cited by 1,709
CTCF mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus
Hark, A. T., Schoenherr, C. J., Katz, D. J., Ingram, R. S., Levorse, J. M., & Tilghman, S. M. (2000) · Nature · doi:10.1038/35013106 · Cited by 1,547
Insulator dysfunction and oncogene activation in IDH mutant gliomas
Flavahan, W. A., Drier, Y., Liau, B. B., Gillespie, S. M., Venteicher, A. S., Stemmer-Rachamimov, A. O., Suvà, M. L., & Bernstein, B. E. (2016) · Nature · doi:10.1038/nature16490 · Cited by 1,288
Self-citationEditing DNA Methylation in the Mammalian Genome
Liu, X. S., Wu, H., Ji, X., Stelzer, Y., Wu, X., Czauderna, S., Shu, J., Dadon, D., Young, R. A., & Jaenisch, R. (2016) · Cell · doi:10.1016/j.cell.2016.08.056 · Cited by 1,224
Activation of proto-oncogenes by disruption of chromosome neighborhoods
Hnisz, D., Weintraub, A. S., Day, D. S., Valton, A.-L., Bak, R. O., Li, C. H., Goldmann, J., Lajoie, B. R., Fan, Z. P., Sigova, A. A., et al. (2016) · Science · doi:10.1126/science.aad9024 · Cited by 1,042
Thakore, P. I., D'Ippolito, A. M., Song, L., Safi, A., Shivakumar, N. K., Kabadi, A. M., Reddy, T. E., Crawford, G. E., & Gersbach, C. A. (2015) · Nature Methods · doi:10.1038/nmeth.3630 · Cited by 1,012
Reconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Suvà, M. L., Rheinbay, E., Gillespie, S. M., Patel, A. P., Wakimoto, H., Rabkin, S. D., Riggi, N., Chi, A. S., Cahill, D. P., Nahed, B. V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.030 · Cited by 956
Self-citationA compendium of chromatin contact maps reveals spatially active regions in the human genome
Schmitt, A. D., Hu, M., Jung, I., Xu, Z., Qiu, Y., Tan, C. L., Li, Y., Lin, S., Lin, Y., Barr, C. L., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.061 · Cited by 866
Repurposing the CRISPR-Cas9 system for targeted DNA methylation
Vojta, A., Dobrinić, P., Tadić, V., Bočkor, L., Korać, P., Jülg, B. D., Klasić, M., & Zoldoš, V. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw159 · Cited by 796
Cohesin and CTCF differentially affect chromatin architecture and gene expression in human cells
Zuin, J., Dixon, J. R., van der Reijden, M. I. J. A., Ye, Z., Kolovos, P., Brouwer, R. W. W., van de Corput, M. P. C., van de Werken, H. J. G., Knoch, T. A., van IJcken, W. F. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317788111 · Cited by 779
Thomas, P. D. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg115 · Cited by 665
Functional annotation of native enhancers with a Cas9–histone demethylase fusion
Kearns, N. A., Pham, H., Tabak, B., Genga, R. M., Silverstein, N. J., Garber, M., & Maehr, R. (2015) · Nature Methods · doi:10.1038/nmeth.3325 · Cited by 656
Systematic mapping of functional enhancer–promoter connections with CRISPR interference
Fulco, C. P., Munschauer, M., Anyoha, R., Munson, G., Grossman, S. R., Perez, E. M., Kane, M., Cleary, B., Lander, E. S., & Engreitz, J. M. (2016) · Science · doi:10.1126/science.aag2445 · Cited by 643
Defining and improving the genome-wide specificities of CRISPR–Cas9 nucleases
Tsai, S. Q., & Joung, J. K. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.28 · Cited by 520
Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing
Amabile, A., Migliara, A., Capasso, P., Biffi, M., Cittaro, D., Naldini, L., & Lombardo, A. (2016) · Cell · doi:10.1016/j.cell.2016.09.006 · Cited by 516
Klann, T. S., Black, J. B., Chellappan, M., Safi, A., Song, L., Hilton, I. B., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2017) · Nature Biotechnology · doi:10.1038/nbt.3853 · Cited by 447
Insulated Neighborhoods: Structural and Functional Units of Mammalian Gene Control
Hnisz, D., Day, D. S., & Young, R. A. (2016) · Cell · doi:10.1016/j.cell.2016.10.024 · Cited by 420
3D Chromosome Regulatory Landscape of Human Pluripotent Cells
Ji, X., Dadon, D. B., Powell, B. E., Fan, Z. P., Borges-Rivera, D., Shachar, S., Weintraub, A. S., Hnisz, D., Pegoraro, G., Lee, T. I., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2015.11.007 · Cited by 400
Robust 4C-seq data analysis to screen for regulatory DNA interactions
van de Werken, H. J. G., Landan, G., Holwerda, S. J. B., Hoichman, M., Klous, P., Chachik, R., Splinter, E., Valdes‐Quezada, C., Öz, Y., Bouwman, B. A. M., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2173 · Cited by 391
Efficient targeted DNA methylation with chimeric dCas9–Dnmt3a–Dnmt3L methyltransferase
Stepper, P., Kungulovski, G., Jurkowska, R. Z., Chandra, T., Krueger, F., Reinhardt, R., Reik, W., Jeltsch, A., & Jurkowski, T. P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1112 · Cited by 340
Ram, O., Goren, A., Amit, I., Shoresh, N., Yosef, N., Ernst, J., Kellis, M., Gymrek, M., Issner, R., Coyne, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.057 · Cited by 331
Self-citationReprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation
McDonald, J. I., Celik, H., Rois, L. E., Fishberger, G., Fowler, T., Rees, R., Kramer, A. C., Martens, A., Edwards, J. R., & Challen, G. A. (2016) · Biology Open · doi:10.1242/bio.019067 · Cited by 283
Rheinbay, E., Suvà, M. L., Gillespie, S. M., Wakimoto, H., Patel, A. P., Shahid, M., Oksuz, O., Rabkin, S. D., Martuza, R. L., Rivera, M. N., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.04.021 · Cited by 283
Self-citationO’Geen, H., Ren, C., Nicolet, C. M., Perez, A. A., Halmai, J. A. N. M., Le, V. M., Mackay, J. P., Farnham, P., & Segal, D. J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx578 · Cited by 249
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
Wakimoto, H., Mohapatra, G., Kanai, R., Curry, W. T., Yip, S. S. F., Nitta, M., Patel, A. P., Barnard, Z. R., Stemmer-Rachamimov, A. O., Louis, D. N., et al. (2011) · Neuro-Oncology · doi:10.1093/neuonc/nor195 · Cited by 245
Splinter, E., de Wit, E., van de Werken, H. J. G., Klous, P., & de Laat, W. L. (2012) · Methods · doi:10.1016/j.ymeth.2012.04.009 · Cited by 228
DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A
Huang, Y., Su, J., Lei, Y., Brunetti, L., Gundry, M. C., Zhang, X., Jeong, M., Li, W., & Goodell, M. A. (2017) · Genome biology · doi:10.1186/s13059-017-1306-z · Cited by 220
De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET
Rowe, H. M., Friedli, M., Offner, S., Verp, S., Mesnard, D., Marquis, J., Aktaş, T., & Trono, D. (2013) · Development · doi:10.1242/dev.087585 · Cited by 192
Ezh2-dCas9 and KRAB-dCas9 enable engineering of epigenetic memory in a context-dependent manner
O’Geen, H., Bates, S. L., Carter, S., Nisson, K., Halmai, J. A. N. M., Fink, K. D., Rhie, S. K., Farnham, P., & Segal, D. J. (2019) · Epigenetics & Chromatin · doi:10.1186/s13072-019-0275-8 · Cited by 173
Genome-wide tracking of dCas9-methyltransferase footprints
Galonska, C., Charlton, J., Mattei, A. L., Donaghey, J., Clement, K., Gu, H., Mohammad, A. W., Stamenova, E. K., Cacchiarelli, D., Klages, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02708-5 · Cited by 160
Mlambo, T., Nitsch, S., Hildenbeutel, M., Romito, M., Müller, M., Bossen, C., Diederichs, S., Cornu, T. I., Cathomen, T., & Mussolino, C. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky171 · Cited by 99
4C-ker: A Method to Reproducibly Identify Genome-Wide Interactions Captured by 4C-Seq Experiments
Raviram, R., Rocha, P. P., Müller, C. L., Miraldi, E. R., Badri, S., Fu, Y., Swanzey, E., Proudhon, C., Snetkova, V., Bonneau, R., et al. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004780 · Cited by 92
Flagged first, then by citations
Cited by
Sorted by citations
Activity-by-contact model of enhancer–promoter regulation from thousands of CRISPR perturbations
Fulco, C. P., Nasser, J., Jones, T. R., Munson, G., Bergman, D. T., Subramanian, V., Grossman, S. R., Anyoha, R., Doughty, B. R., Patwardhan, T. A., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0538-0 · Cited by 1,111
Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing
Nuñez, J. K., Chen, J., Pommier, G. C., Cogan, J. Z., Replogle, J. M., Adriaens, C., Ramadoss, G. N., Shi, Q., Hung, K. L., Samelson, A. J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.025 · Cited by 760
Self-citationCRISPR technologies for precise epigenome editing
Nakamura, M., Gao, Y., Dominguez, A. A., & Qi, L. S. (2021) · Nature Cell Biology · doi:10.1038/s41556-020-00620-7 · Cited by 456
CRISPR in cancer biology and therapy
Katti, A., Diaz, B. J., Caragine, C. M., Sanjana, N. E., & Dow, L. E. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00441-w · Cited by 451
Understanding 3D genome organization by multidisciplinary methods
Jerković, I., & Cavalli, G. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00362-w · Cited by 413
CRISPR technologies for genome, epigenome and transcriptome editing
Villiger, L., Joung, J., Koblan, L. W., Weissman, J. S., Abudayyeh, O. O., & Gootenberg, J. S. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00697-6 · Cited by 280
CRISPR/dCas9 Tools: Epigenetic Mechanism and Application in Gene Transcriptional Regulation
Cai, R., Lv, R., Shi, X., Yang, G., & Jin, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914865 · Cited by 186
Single-cell DNA methylome and 3D multi-omic atlas of the adult mouse brain
Liu, H., Zeng, Q., Zhou, J., Bartlett, A., Wang, B.-A., Berube, P., Tian, W., Kenworthy, M., Altshul, J., Nery, J. R., et al. (2023) · Nature · doi:10.1038/s41586-023-06805-y · Cited by 139
Advances of epigenetic editing
Gjaltema, R. A. F., & Rots, M. G. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2020.04.020 · Cited by 114
Drugging the epigenome in the age of precision medicine
Feehley, T., O’Donnell, C. W., Mendlein, J. D., Karande, M., & McCauley, T. (2023) · Clinical Epigenetics · doi:10.1186/s13148-022-01419-z · Cited by 110
Regulation and functional roles of chemokines in liver diseases
Cao, S., Liu, M., Sehrawat, T. S., & Shah, V. H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00444-2 · Cited by 106
Identification of non-coding silencer elements and their regulation of gene expression
Pang, B., van Weerd, J. H., Hamoen, F. L., & Snyder, M. P. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00549-9 · Cited by 101
Wu, Q., Guo, Y., Lu, Y., Li, J., Guo, Y., & Jia, Z. (2020) · Genome biology · doi:10.1186/s13059-020-01984-7 · Cited by 84
Modulating gene regulation to treat genetic disorders
Matharu, N. K., & Ahituv, N. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0083-7 · Cited by 78
Functional Genomics for Cancer Drug Target Discovery
Haley, B., & Roudnicky, F. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.04.006 · Cited by 75
The impact of DNA methylation on CTCF-mediated 3D genome organization
Monteagudo, A., Noordermeer, D., & Greenberg, M. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01241-6 · Cited by 70
Zhang, S., Plummer, D., Lu, L., Cui, J., Xu, W., Wang, M., Liu, X., Prabhakar, N., Shrinet, J., Srinivasan, D., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01116-w · Cited by 63
Engineering 3D genome organization
Wang, H., Han, M., & Qi, L. S. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00325-5 · Cited by 62
Regulation of 3D chromatin organization by CTCF
Xiang, J., & Corces, V. G. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.10.005 · Cited by 58
Epigenetic editing: Dissecting chromatin function in context
Policarpi, C., Dabin, J., & Hackett, J. A. (2021) · BioEssays · doi:10.1002/bies.202000316 · Cited by 54
Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer
Tang, S. C., Vijayakumar, U., Zhang, Y., & Fullwood, M. J. (2022) · Cancers · doi:10.3390/cancers14122866 · Cited by 56
Roth, G. V., Gengaro, I. R., & Qi, L. S. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.07.007 · Cited by 57
Targeted epigenetic repression by CRISPR/dSaCas9 suppresses pathogenic DUX4-fl expression in FSHD
Himeda, C. L., Jones, T. I., & Jones, P. L. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.12.001 · Cited by 54
Gjaltema, R. A. F., Schwämmle, T., Kautz, P., Robson, M. I., Schöpflin, R., Lustig, L. R., Brandenburg, L., Dunkel, I., Vechiatto, C., Ntini, E., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.11.023 · Cited by 48
Ma, Q., Yang, L., Tolentino, K., Wang, G., Zhao, Y., Litzenburger, U. M., Shi, Q., Zhu, L., Yang, C., Jiao, H., et al. (2022) · eLife · doi:10.7554/elife.79126 · Cited by 48
Dissection of a CTCF topological boundary uncovers principles of enhancer-oncogene regulation
Kim, K. L., Rahme, G. J., Goel, V. Y., Farran, C. A. E., Hansen, A. S., & Bernstein, B. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.02.007 · Cited by 42
Self-citationAlariqi, M., Ramadan, M., Yu, L., Hui, F., Hussain, A., Zhou, X., Yu, Y., Zhang, X., & Jin, S. (2025) · Advanced Science · doi:10.1002/advs.202416331 · Cited by 42
Liesenfelder, S., Mabrouk, M. H. E., Iliescu, J., Baranda, M. V., Mizi, A., Perez-Correa, J.-F., Wessiepe, M., Papantonis, A., & Wagner, W. (2025) · Nature Aging · doi:10.1038/s43587-025-00841-1 · Cited by 39
DNA Methylation-Governed Gene Expression in Autoimmune Arthritis
Brandt, B., Rashidiani, S., Bán, Á., & Rauch, T. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225646 · Cited by 35
Gualdrini, F., Polletti, S., Simonatto, M., Prosperini, E., Pileri, F., & Natoli, G. (2022) · Genes & Development · doi:10.1101/gad.349282.121 · Cited by 35
Using CRISPR to understand and manipulate gene regulation
Akıncı, E., Hamilton, M. C., Khowpinitchai, B., & Sherwood, R. I. (2021) · Development · doi:10.1242/dev.182667 · Cited by 36
Spatial promoter–enhancer hubs in cancer: organization, regulation, and function
Zhao, J., & Faryabi, R. B. (2023) · Trends in Cancer · doi:10.1016/j.trecan.2023.07.017 · Cited by 28
Integrated epigenetic and genetic programming of primary human T cells
Goudy, L., Ha, A. S., Borah, A. A., Umhoefer, J. M., Chow, L., Tran, C., Winters, A., Talbot, A., Hernandez, R., Li, Z., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02856-w · Cited by 38
Epigenetic editing: from concept to clinic
Heller, E. A., Bintu, L., & Rots, M. G. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01323-0 · Cited by 37
Kovalev, M. A., Mamaeva, N. Y., Kristovskiy, N. V., Feskin, P. G., Vinnikov, R. S., Oleinikov, P. D., Sosnovtseva, A. O., Yakovlev, V. A., Glukhov, G. S., & Shaytan, A. К. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136371 · Cited by 29
Durable CRISPR-Based Epigenetic Silencing
Nakamura, M., Ivec, A. E., Gao, Y., & Qi, L. S. (2021) · BioDesign Research · doi:10.34133/2021/9815820 · Cited by 26
Gene-Targeted DNA Methylation: Towards Long-Lasting Reprogramming of Gene Expression?
Cortés-Mancera, F., Sarno, F., Goubert, D., & Rots, M. G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11454-0_18 · Cited by 25
Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system
Wang, L., & Han, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e38588 · Cited by 26
Epigenome editing based treatment: Progresses and challenges
Yuan, L., Xiong, Y., Zhang, Y., Gu, S., & Lei, Y. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.08.047 · Cited by 27
Long-range gene regulation in hormone-dependent cancer
Tettey, T. T., Rinaldi, L., & Hager, G. L. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00603-4 · Cited by 23
Sesé, B., Ensenyat-Méndez, M., Íñiguez-Muñoz, S., Llinàs‐Arias, P., & Marzese, D. M. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01139-w · Cited by 20
A review of the role of epigenetic studies for intramuscular fat deposition in beef cattle
Abebe, B. K., Wang, J., Guo, J., Wang, H., Li, A., & Zan, L. (2024) · Gene · doi:10.1016/j.gene.2024.148295 · Cited by 21
The impact of the embryonic DNA methylation program on CTCF-mediated genome regulation
Monteagudo, A., Albert, J. R., Scarpa, M., Noordermeer, D., & Greenberg, M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae724 · Cited by 22
Chen, Y., Luo, X. L., Kang, R., Cui, K., Ou, J., Zhang, X., & Liang, P. (2023) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2023.07.007 · Cited by 23
Sapozhnikov, D. M., & Szyf, M. (2022) · Nature Protocols · doi:10.1038/s41596-022-00741-3 · Cited by 20
Genome-Wide Chromatin Analysis of FFPE Tissues Using a Dual-Arm Robot with Clinical Potential
Kaneko, S., Mitsuyama, T., Shiraishi, K., Ikawa, N., Shozu, K., Dozen, A., Machino, H., Asada, K., Komatsu, M., Kukita, A., et al. (2021) · Cancers · doi:10.3390/cancers13092126 · Cited by 18
Rosenberg, T., Marco, A., Kisliouk, T., Haron, A., Shinder, D., Druyan, S., & Meiri, N. (2022) · The FASEB Journal · doi:10.1096/fj.202101948r · Cited by 17
Mowery, C. T., Freimer, J. W., Chen, Z., Casaní-Galdón, S., Umhoefer, J. M., Arce, M. M., Gjoni, K., Dániel, B., Sándor, K., Gowen, B. G., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01743-5 · Cited by 18
Self-citationNext-generation CRISPR technology for genome, epigenome and mitochondrial editing
Lau, C., Liang, Q., & Zhu, H. (2024) · Transgenic Research · doi:10.1007/s11248-024-00404-x · Cited by 19
Schrauben, M., Dempster, E. L., & Lunnon, K. (2020) · Brain Pathology · doi:10.1111/bpa.12881 · Cited by 17
Martella, A., & Fisher, D. I. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0108 · Cited by 14
Harnessing targeted DNA methylation and demethylation using dCas9
Pflueger, C., Swain, T., & Lister, R. (2019) · Essays in Biochemistry · doi:10.1042/ebc20190029 · Cited by 18
CRISPR-based functional genomics tools in vertebrate models
Varshney, G. K., & Burgess, S. M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01514-0 · Cited by 18
3D genome alterations and editing in pathology
Tiukacheva, E. A., Ulianov, S. V., Karpukhina, A. A., Razin, S. V., & Vassetzky, Y. S. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.005 · Cited by 14
Chromatin structure and context-dependent sequence features control prime editing efficiency
Kim, S., Yuan, J. B., Woods, W. S., Newton, D. A., Perez-Pinera, P., & Song, J. S. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1222112 · Cited by 12
Genome-wide CRISPR screens for the identification of therapeutic targets for cancer treatment
Xue, V. W., Wong, S. C. C., & Cho, W. C. S. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1820986 · Cited by 11
Applications of CRISPR Epigenome Editors in Tumor Immunology and Autoimmunity
Yahsi, B., Palaz, F., & Dinçer, P. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00524 · Cited by 10
Guerra-Resendez, R. S., Lydon, S. L., Ma, A. J., Bedford, G. C., Reed, D. R., Kim, S. H., Terán, E. R., Nishiguchi, T., Escobar, M., DiNardo, A. R., et al. (2025) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00569 · Cited by 8
dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer
Zamberi, N. N. M., Abuhamad, A. Y., Low, T. Y., Mohtar, M. A., & Syafruddin, S. E. (2024) · The CRISPR Journal · doi:10.1089/crispr.2023.0078 · Cited by 8
Harnessing CRISPR-Cas9 for Epigenetic Engineering
Guerra-Resendez, R. S., & Hilton, I. B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2421-0_14 · Cited by 8
Hamilton, P. J., Lim, C. J., Nestler, E. J., & Heller, E. A. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-4051-7_6 · Cited by 7
Disruption of TAD hierarchy promotes LTR co-option in cancer
Wong, E. W. P., Şahin, M., Yang, R., Lee, U., Li, D., Zhan, Y. A., Misra, R., Tomas, F. V., Alomran, N., Polyzos, A., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02239-6 · Cited by 9
The Promise of Epigenetic Editing for Treating Brain Disorders
González-Molina, L. A., Dolga, A. M., Rots, M. G., & Sarno, F. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-75980-2_4 · Cited by 5
SBTD: A Novel Method for Detecting Topological Associated Domains from Hi-C Data
Long, C., Liao, Y., Li, Y., Yan, J., Zhu, M., & Li, M. (2021) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-021-00453-4 · Cited by 4
Rewriting the epigenome: CRISPR tools for biological discovery and therapeutics
Otero, C., & Qi, L. S. (2026) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2026.100658 · Cited by 4
Unraveling the interplay of DNA methylation and chromosome organization
Pei, Y., & Li, G. (2025) · Biochemical Society Transactions · doi:10.1042/bst20253094 · Cited by 2
Grand challenge in chromatin epigenomics: everything, everywhere, all at once
Dent, S. (2023) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2023.1195690 · Cited by 2
Targeting the 3D genome by anthracyclines for chemotherapeutic effects
Tan, M., Sun, S., Liu, Y., Perreault, A. A., Phanstiel, D. H., Dou, L., & Pang, B. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2500704122 · Cited by 5
Applications of CRISPRi and CRISPRa in Drug Discovery
Gilbert, L. A. (2022) · Wiley eBooks · doi:10.1002/9781119671404.ch10 · Cited by 2
The chromatin tapestry as a framework for neurodevelopmentPreprint
Nolan, B., Reznicek, T. E., Cummings, C. T., & Rowley, M. J. (2024) · Genome Research · doi:10.1101/gr.278408.123 · Cited by 2
Engineering the Link: From Genome Interaction Maps to Functional Insight
Petersen, F., Westermann, S., Smialkovska, V., Mathony, J., Feldmann, A., & Niopek, D. (2025) · Advanced Biology · doi:10.1002/adbi.202500525 · Cited by 2
Silencing of human HTT by targeted CRISPR/dCas9-mediated epigenetic editing
Tay, Y. L., Thomson, S. B., Hnatova, S., Ng, S., Teo, S. R., McCallum, R. T., Sim, B., Tarantini, L., Tai, F. L., Bollati, V., et al. (2026) · Journal of Huntington s Disease · doi:10.1177/18796397251415368 · Cited by 1
Eskandani, N. A., Mirzaee, D., Farani, M. R., Hatami, A., Hatami, M., Ghasemzaei, M., Ghoreishian, S. M., Hwang, S.-K., & Huh, Y. S. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115921 · Cited by 2
Blokhina, Y. P., & Buchwalter, A. L. (2024) · PLoS ONE · doi:10.1371/journal.pone.0310626 · Cited by 1
Wong, E. W. P., Şahin, M., Yang, R., Lee, U., Zhan, Y. A., Misra, R., Tomas, F. V., Alomran, N., Polyzos, A., Lee, C. J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.31.596845 · Cited by 1
Molecular mechanisms of YY1 overexpression in human cancers and its prognostic significance
Gabriele, M., Testa, G., & Hansen, A. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821909-6.00015-8
Development and Vision of CRISPR-Based Technology
Zhang, Z., Wang, P., & Liu, J. (2022) · Springer eBooks · doi:10.1007/978-981-16-8504-0_1
Fujita, T., & Fujii, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91909-8.00020-7
Epigenetic Contributions to Human Cancer
Baylin, S. B. (2022) · Wiley eBooks · doi:10.1002/9781119000822.hfcm006.pub2
CHD7 binds to insulators during neuronal differentiationPreprint
Qiu, J., Jadali, A., Martinez, E. A., Song, Z., Ni, J. Z., & Kwan, K. Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.28.646031
Molecular Targets of Epigenetic Regulators
Amirmahani, F., Kumar, S., & Muthukrishnan, S. D. (2025) · Springer eBooks · doi:10.1007/978-981-96-7336-0_4
Jia, Z., Li, J., Ge, X., Wu, Y., Guo, Y., & Wu, Q. (2020) · Figshare · doi:10.6084/m9.figshare.12211295
Jia, Z., Li, J., Ge, X., Wu, Y., Guo, Y., & Wu, Q. (2020) · Figshare · doi:10.6084/m9.figshare.12211298
Jia, Z., Li, J., Ge, X., Wu, Y., Guo, Y., & Wu, Q. (2020) · Figshare · doi:10.6084/m9.figshare.12211304
Cui, J., Xu, W., Lang, X., Zhang, S., Lu, L., Liu, X., Li, Y., & Jin, F. (2026) · Nature Communications · doi:10.1038/s41467-026-75801-3
Optimization of AsCas12f1-mediated long-term gene repression
Sun, Y., Li, L., Wang, X., Han, L., Zhao, Y., Tan, Y., Feng, Y., Qi, W., & Ma, H. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.09.001
3D Genome Engineering Using CRISPR/dCas Systems
Mamaeva, N. Y., Yakovlev, V. A., Kristovskiy, N. V., Feskin, P. G., Vinnikov, R. S., Oleinikov, P. D., Shmakov, S., Шайтан, К. В., Kirpichnikov, M. P., & Shaytan, A. К. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27188104
Locus-specific rewriting of DNA methylation in mammalian cells
Xu, D., Christenson, A. E., Phan, N., Moreno, B. D., & Nuñez, J. K. (2026) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2026.102764
Metadata
- Authors
- Tarjan, D. R., Flavahan, W. A., & Bernstein, B. E.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Bernstein, Bradley E.
- Venue
- Nature Communications
- Published
- 2019-09-18
- Volume
- 10
- Issue
- 1
- Pages
- 4258-4258
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC6751197
- OpenAlex
- W2974053118
- Cited by
- 88
- References
- 37
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 15 · 2023: 9 · 2022: 14 · 2021: 14 · 2020: 11 · 2019: 3
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (DP1CA216873)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- topologically associating domains, epigenome editing, dCas9, DNMT3A, DNA methylation, chromatin looping, enhancer-gene interactions, brain tumorigenesis, genome organization, transcriptional repression
- MeSH terms
- Gene Editing, CCCTC-Binding Factor, CRISPR-Associated Protein 9, DNA Methyltransferase 3A, Brain Neoplasms, Cell Line, DNA (Cytosine-5-)-Methyltransferases, Humans, Promoter Regions, Genetic, Recombinant Fusion Proteins, Repressor Proteins, Genome, Human, DNA Methylation, Epigenesis, Genetic, HEK293 Cells, Carcinogenesis, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review